BiomedicineNews.net

Biomedicine Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Diffuse large B-cell lymphoma"

Findings from an ongoing phase IIa study to evaluate the safety and efficacy of investigational chimeric antigen receptor T cell ( CART ) therapy CTL019 in certain types of relapsed or refractory ( r/ ...


The FDA ( Food and Drug Administration ) has approved Yescarta ( Axicabtagene ciloleucel ), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not ...


The U.S. Food and Drug Administration ( FDA ) has approved Breyanzi ( Lisocabtagene maraleucel; Liso-cel ), a CD19-directed chimeric antigen receptor ( CAR ) T cell therapy for the treatment of adult ...


The U.S. Food and Drug Administration ( FDA ) has granted accelerated approval to Yescarta ( Axicabtagene ciloleucel ) for the treatment of adult patients with relapsed or refractory follicular lympho ...